June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Frequent hypomorphic alleles solve 80% of late-onset ABCA4 disease and distinguish it from age-related macular degeneration
Author Affiliations & Notes
  • Rando Allikmets
    Ophthalmology, Columbia University, New York, New York, United States
  • Jana Zernant
    Ophthalmology, Columbia University, New York, New York, United States
  • Frederick T Collison
    Chicago Lthouse for the Blind & Vis Impaired, Chicago, Illinois, United States
  • Gerald A Fishman
    Chicago Lthouse for the Blind & Vis Impaired, Chicago, Illinois, United States
  • Yuri V Sergeev
    OGVFB, National Eye Institute, Bethesda, Maryland, United States
  • Kaspar Schuerch
    Ophthalmology, Columbia University, New York, New York, United States
  • Janet R Sparrow
    Ophthalmology, Columbia University, New York, New York, United States
  • Stephen Tsang
    Ophthalmology, Columbia University, New York, New York, United States
  • Winston Lee
    Ophthalmology, Columbia University, New York, New York, United States
  • Footnotes
    Commercial Relationships   Rando Allikmets, None; Jana Zernant, None; Frederick Collison, None; Gerald Fishman, None; Yuri Sergeev, None; Kaspar Schuerch, None; Janet Sparrow, None; Stephen Tsang, None; Winston Lee, None
  • Footnotes
    Support  NIH grants EY021163, EY019861, EY021237 and EY019007 and Research to Prevent Blindness (New York, NY)
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1240. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Rando Allikmets, Jana Zernant, Frederick T Collison, Gerald A Fishman, Yuri V Sergeev, Kaspar Schuerch, Janet R Sparrow, Stephen Tsang, Winston Lee; Frequent hypomorphic alleles solve 80% of late-onset ABCA4 disease and distinguish it from age-related macular degeneration
      . Invest. Ophthalmol. Vis. Sci. 2017;58(8):1240.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Variation in the ABCA4 gene is causal for, or associated with, a wide range of phenotypes from early-onset Mendelian retinal dystrophies to late-onset complex disorders such as age-related macular degeneration (AMD). However, a significant fraction of the disease-associated genetic variation has remained elusive thereby complicating assessment of the role of monoallelic and biallelic variants in clinically confirmed disease.

Methods : All 645 study subjects diagnosed with ABCA4 disease underwent complete ophthalmic examinations, including autofluorescence (AF) imaging with cSLO and SD-OCT scans. The ABCA4 gene and locus sequencing were performed using the Illumina TruSeq Custom Amplicon protocol followed by confirmation of variants by Sanger sequencing. The possible effect of ABCA4 variants was assessed with prediction algorithms via Alamut and the allele frequencies of all variants were compared to the gnomAD database or the 1000 Genomes Project database. Protein unfolding propensities for selected ABCA4 variants were evaluated with the unfolding mutation screen.

Results : We determined that some ABCA4 variants, previously considered benign due to high minor allele frequency (MAF 2-7%) in the general population, account for a large fraction of missing pathogenic alleles, particularly in monoallelic cases. We show that a hypomorphic c.5603A>T (p.Asn1868Ile) variant with MAF ~7% in the general population accounts for a large fraction of missing pathogenic alleles. It explains >50% of monoallelic cases, ~80% of late-onset cases and distinguishes ABCA4 disease from AMD. We also identify intragenic modifying effects of another, c.2588G>C (p.Gly863Ala), allele and describe distinct clinical phenotype(s) conferred by these alleles.

Conclusions : Our findings substantiate the causality of frequent missense variants and their phenotypic outcomes as a significant contribution to ABCA4 disease and its clinical presentation.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×